AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
COMMON TREATMENT GOALS - SWITCHING ANTIPSYCHOTICS
Authors: WEIDEN P
Citation: P. Weiden, COMMON TREATMENT GOALS - SWITCHING ANTIPSYCHOTICS, American journal of managed care, 4, 1998, pp. 23-30
INITIAL CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENT QUALITY-OF-LIFE
Authors: MORROW GR ROSCOE JA HICKOK JT STERN RM PIERCE HI KING DB BANERJEE TK WEIDEN P
Citation: Gr. Morrow et al., INITIAL CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENT QUALITY-OF-LIFE, Oncology, 12(3), 1998, pp. 32-37
HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) RESCUE IN PATIENTS WITH ADVANCED-STAGE III IV OVARIAN-CANCER/
Authors: HOLMBERG LA DEMIRER T ROWLEY S BUCKNER CD GOODMAN G MAZIARZ R KLARNET J ZUCKERMAN N HARRER G MCCLOSKEY R GERSH R GOLDBERG R NICHOLS W JACOBS A WEIDEN P MONTGOMERY P RIVKIN S APPELBAUM FR BENSINGER WI
Citation: La. Holmberg et al., HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) RESCUE IN PATIENTS WITH ADVANCED-STAGE III IV OVARIAN-CANCER/, Bone marrow transplantation, 22(7), 1998, pp. 651-659
PRETARGETED RADIOIMMUNOTHERAPY(TM) WITH ANTIBODY-STREPTAVIDIN AND Y-90 DOTA-BIOTIN (AVICIDIN(R)) - RESULT OF A DOSE-ESCALATION STUDY
Authors: BREITZ H KNOX S WEIDEN P GORIS M MURTHA A BRYAN J AXWORTHY D SEILER C SU FM BEAUMIER P RENO J
Citation: H. Breitz et al., PRETARGETED RADIOIMMUNOTHERAPY(TM) WITH ANTIBODY-STREPTAVIDIN AND Y-90 DOTA-BIOTIN (AVICIDIN(R)) - RESULT OF A DOSE-ESCALATION STUDY, The Journal of nuclear medicine, 39(5), 1998, pp. 272-272
HIGH-DOSE BUSULFAN, MELPHALAN, THIOTEPA AND PERIPHERAL-BLOOD STEM-CELL INFUSION FOR THE TREATMENT OF METASTATIC BREAST-CANCER
Authors: BENSINGER WI SCHIFFMAN KS HOLMBERG L APPELBAUM FR MAZIARZ R MONTGOMERY P ELLIS E RIVKIN S WEIDEN P LILLEBY K ROWLEY S PETERSDORF S KLARNET JP NICHOLS W HERTLER A MCCROSKEY R WEAVER CH BUCKNER CD
Citation: Wi. Bensinger et al., HIGH-DOSE BUSULFAN, MELPHALAN, THIOTEPA AND PERIPHERAL-BLOOD STEM-CELL INFUSION FOR THE TREATMENT OF METASTATIC BREAST-CANCER, Bone marrow transplantation, 19(12), 1997, pp. 1183-1189
SAFETY OF OLANZAPINE CROSSOVER FOR STABLE OUTPATIENTS WITH SCHIZOPHRENIA
Authors: WEIDEN P AQUILA R DALHEIM L
Citation: P. Weiden et al., SAFETY OF OLANZAPINE CROSSOVER FOR STABLE OUTPATIENTS WITH SCHIZOPHRENIA, Psychopharmacology bulletin, 33(3), 1997, pp. 602-602
ASSESSMENT AND TREATMENT SELECTION FOR REVOLVING-DOOR INPATIENTS WITHSCHIZOPHRENIA
Authors: WEIDEN P GLAZER W
Citation: P. Weiden et W. Glazer, ASSESSMENT AND TREATMENT SELECTION FOR REVOLVING-DOOR INPATIENTS WITHSCHIZOPHRENIA, Psychiatric quarterly, 68(4), 1997, pp. 377-392
ASSERTIVE COMMUNITY TREATMENT AND MEDICATION COMPLIANCE IN THE HOMELESS MENTALLY-ILL
Authors: DIXON L WEIDEN P TORRES M LEHMAN A
Citation: L. Dixon et al., ASSERTIVE COMMUNITY TREATMENT AND MEDICATION COMPLIANCE IN THE HOMELESS MENTALLY-ILL, The American journal of psychiatry, 154(9), 1997, pp. 1302-1304
SYNGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: BENSINGER WI DEMIRER T BUCKNER CD APPELBAUM FR STORB R LILLEBY K WEIDEN P BLUMING AZ FEFER A
Citation: Wi. Bensinger et al., SYNGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA, Bone marrow transplantation, 18(3), 1996, pp. 527-531
PHASE-II STUDY OF HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT DISEASE
Authors: SCHIFFMAN KS BENSINGER WI APPELBAUM FR ROWLEY S LILLEBY K CLIFT RA WEAVER CH DEMIRER T SANDERS JE PETERSDORF S GOOLEY T WEIDEN P ZUCKERMAN N MONTGOMERY P MAZIARZ R KLARNET JP RIVKIN S TRUEBLOOD K STORB R HOLMBERG L BUCKNER CD
Citation: Ks. Schiffman et al., PHASE-II STUDY OF HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT DISEASE, Bone marrow transplantation, 17(6), 1996, pp. 943-950
TRANSITION FROM ACUTE TO MAINTENANCE TREATMENT - PREDICTION OF STABILIZATION
Authors: SCHOOLER NR SEVERE JB GLICK ID HARGREAVES WA KEITH SJ WEIDEN P MATTHEWS SM SCHULTZ SC ODBERT CL KANE JM LIEBERMAN JA WOERNER M BELLACK AS SIMPSON GM FRANCES AJ JACOBS M NINAN PT MANCE RM FALLOON IRH MCGILL CW
Citation: Nr. Schooler et al., TRANSITION FROM ACUTE TO MAINTENANCE TREATMENT - PREDICTION OF STABILIZATION, International clinical psychopharmacology, 11, 1996, pp. 85-91
ATYPICAL ANTIPSYCHOTIC-DRUGS AND LONG-TERM OUTCOME IN SCHIZOPHRENIA
Authors: WEIDEN P AQUILA R STANDARD J
Citation: P. Weiden et al., ATYPICAL ANTIPSYCHOTIC-DRUGS AND LONG-TERM OUTCOME IN SCHIZOPHRENIA, The Journal of clinical psychiatry, 57, 1996, pp. 53-60
POSTDISCHARGE MEDICATION COMPLIANCE OF INPATIENTS CONVERTED FROM AN ORAL TO A DEPOT NEUROLEPTIC REGIMEN
Authors: WEIDEN P RAPKIN B ZYGMUNT A MOTT T GOLDMAN D FRANCES A
Citation: P. Weiden et al., POSTDISCHARGE MEDICATION COMPLIANCE OF INPATIENTS CONVERTED FROM AN ORAL TO A DEPOT NEUROLEPTIC REGIMEN, Psychiatric services, 46(10), 1995, pp. 1049-1054
DETERMINANTS OF SUBJECTIVE DISTRESS TO NEUROLEPTICS
Authors: WEIDEN P RAPKIN B ZYGMUNT A
Citation: P. Weiden et al., DETERMINANTS OF SUBJECTIVE DISTRESS TO NEUROLEPTICS, Schizophrenia research, 15(1-2), 1995, pp. 211-211
FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS
Authors: BENSINGER W APPELBAUM F ROWLEY S STORB R SANDERS J LILLEBY K GOOLEY T DEMIRER T SCHIFFMAN K WEAVER C CLIFT R CHAUNCEY T KLARNET J MONTGOMERY P PETERSDORF S WEIDEN P WITHERSPOON R BUCKNER CD
Citation: W. Bensinger et al., FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS, Journal of clinical oncology, 13(10), 1995, pp. 2547-2555
HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT-LYMPHOMA
Authors: WEAVER CH PETERSEN FB APPELBAUM FR BENSINGER WI PRESS O MARTIN P SANDMAIER B DEEG HJ HANSEN JA BRUNVAND M ROWLEY S BENYUNES K CHAUNCEY T FEFER A HACKMAN R GOOLEY T SCHIFFMAN K STORB R SULLIVAN KM WEIDEN P WITHERSPOON R BUCKNER CD
Citation: Ch. Weaver et al., HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT-LYMPHOMA, Journal of clinical oncology, 12(12), 1994, pp. 2559-2566
RATING OF MEDICATION INFLUENCES (ROMI) SCALE IN SCHIZOPHRENIA
Authors: WEIDEN P RAPKIN B MOTT T ZYGMUNT A GOLDMAN D HORVITZLENNON M FRANCES A
Citation: P. Weiden et al., RATING OF MEDICATION INFLUENCES (ROMI) SCALE IN SCHIZOPHRENIA, Schizophrenia bulletin, 20(2), 1994, pp. 297-310
PHASE-I STUDY OF HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH REFRACTORY MALIGNANCIES
Authors: WEAVER CH BENSINGER WI APPELBAUM FR LILLEBY K SANDMAIER B BRUNVAND M ROWLEY S PETERSDORF S RIVKIN S GOOLEY T WEIDEN P ZUCKERMAN N MONTGOMERY P TRUEBLOOD K KLARNET J BUCKNER CD
Citation: Ch. Weaver et al., PHASE-I STUDY OF HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH REFRACTORY MALIGNANCIES, Bone marrow transplantation, 14(5), 1994, pp. 813-819
RE-186 LABELED 16.88-IGM AND 88BV59 IGG HUMAN-ANTIBODY STUDIES TO ASSESS POTENTIAL FOR RADIOIMMUNOTHERAPY
Authors: BREITZ H SELLER C WEIDEN P APPELBAUM J RATLIFF B STIEKEMA J KLEIN J RUPPEL S DEJAGER R
Citation: H. Breitz et al., RE-186 LABELED 16.88-IGM AND 88BV59 IGG HUMAN-ANTIBODY STUDIES TO ASSESS POTENTIAL FOR RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000100-160000100
TRAINING IN PSYCHOTHERAPY - REPLY
Authors: WEIDEN P HAVENS L
Citation: P. Weiden et L. Havens, TRAINING IN PSYCHOTHERAPY - REPLY, Hospital & community psychiatry, 45(9), 1994, pp. 938-938
PSYCHOTHERAPEUTIC MANAGEMENT-TECHNIQUES IN THE TREATMENT OF OUTPATIENTS WITH SCHIZOPHRENIA
Authors: WEIDEN P HAVENS L
Citation: P. Weiden et L. Havens, PSYCHOTHERAPEUTIC MANAGEMENT-TECHNIQUES IN THE TREATMENT OF OUTPATIENTS WITH SCHIZOPHRENIA, Hospital & community psychiatry, 45(6), 1994, pp. 549-555
HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAVE RECEIVED DOSE-LIMITING RADIATION-THERAPY
Authors: WEAVER CH APPELBAUM FR PETERSEN FB CLIFT R SINGER J PRESS O BENSINGER W BIANCO J MARTIN P ANASETTI C BADGER C DEEG J DONY K HANSEN JA PETERSDORF E ROWLEY S STORB R SULLIVAN K WITHERSPOON R WEIDEN P BUCKNER CD
Citation: Ch. Weaver et al., HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAVE RECEIVED DOSE-LIMITING RADIATION-THERAPY, Journal of clinical oncology, 11(7), 1993, pp. 1329-1335
AUTOLOGOUS MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED 1ST RELAPSE OR IN 2ND COMPLETE REMISSION
Authors: PETERSEN FB LYNCH MHE CLIFT RA APPELBAUM FR SANDERS JE BENSINGER WI BENYUNES MC DONEY K FEFER A MARTIN P STORB R ROWLEY S SULLIVAN KM WITHERSPOON R WEIDEN P THOMAS ED FISHER L HANSEN JA BUCKNER CD
Citation: Fb. Petersen et al., AUTOLOGOUS MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED 1ST RELAPSE OR IN 2ND COMPLETE REMISSION, Journal of clinical oncology, 11(7), 1993, pp. 1353-1360
STABILIZATION AND DEPOT NEUROLEPTIC DOSAGES
Authors: WEIDEN P SCHOOLER NR SEVERE JB LEE JH SCHULZ SC
Citation: P. Weiden et al., STABILIZATION AND DEPOT NEUROLEPTIC DOSAGES, Psychopharmacology bulletin, 29(2), 1993, pp. 269-275
TREATMENT OF NEUROLEPTIC-RESISTANT SCHIZOPHRENIC RELAPSE
Authors: KINON BJ KANE JM JOHNS C PEROVICH R ISMI M KOREEN A WEIDEN P
Citation: Bj. Kinon et al., TREATMENT OF NEUROLEPTIC-RESISTANT SCHIZOPHRENIC RELAPSE, Psychopharmacology bulletin, 29(2), 1993, pp. 309-314
Risultati: 1-25 | 26-27